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Abstract Sialadenosis (sialosis) has been associated most
oftenwithalcoholicliverdiseaseandalcoholiccirrhosis,but
a number of nutritional deﬁciencies, diabetes, and bulimia
have also been reported to result in sialadenosis. The aim of
this study was to determine the prevalence of sialadenosis in
patients with advanced liver disease. Patients in the study
group consisted of 300 candidates for liver transplantation.
Types of liver disease in subjects with clinical evidence of
sialadenosiswerecomparedwithdiagnosesincaseswhohad
no manifestations of sialadenosis. The data were analyzed
for signiﬁcant association. Sialadenosis was found in 28 of
the 300 subjects (9.3%). Among these 28 cases, 11 (39.3%)
had alcoholic cirrhosis. The remaining 17 (60.7%) had eight
other types of liver disease. There was no signiﬁcant asso-
ciation between sialadenosis and alcoholic cirrhosis
(P = 0.389). These ﬁndings suggest that both alcoholic and
non-alcoholic cirrhosis may lead to the development of
sialadenosis. Advanced liver disease is accompanied by
multiple nutritional deﬁciencies which may be exacerbated
by alcohol. Similar metabolic abnormalities may occur in
patients with diabetes or bulimia. Malnutrition has been
associated with autonomic neuropathy, the pathogenic
mechanism that has been proposed for sialadenosis.
Keywords Sialadenosis  Sialosis  Cirrhosis 
Alcoholic cirrhosis  Parotid glands  Malnutrition
Introduction
Sialadenosis (sialosis) is characterized by bilateral
enlargement of the parotid glands that is asymptomatic,
does not affect salivary gland function, and is not related to
any inﬂammatory or neoplastic process [1, 2]. This con-
dition was initially associated with a number of vitamin
and other nutritional deﬁciencies [3, 4]. Subsequently,
alcoholism and alcoholic cirrhosis became the most fre-
quently cited predisposing factors for sialadenosis [5–7]
with incidence estimates of 30–86% [2, 6, 7]. Nevertheless,
there have been conﬂicting ﬁndings as to whether alco-
holism with or without cirrhosis, or other causes of
cirrhosis can result in sialadenosis [2, 6, 8, 9]. Sialadenosis
has also been observed with anorexia or bulimia nervosa,
diabetes mellitus, obesity, pregnancy, medications, and
exposure to chemicals. [2].
A possible confounding factor contributing to the etio-
pathic overlap between sialadenosis and cirrhosis,
alcoholism, or malnutrition may be related to the fact that
cirrhosis is commonly associated with signiﬁcant nutri-
tional abnormalities in alcoholic as well as non-alcoholic
patients [10–20]. It has been shown that calorie and protein
deﬁciencies may affect nearly all patients who have
developed advanced liver disease [19]. A comparative
study of alcoholics with or without liver disease and
patients with non-alcohol-related liver disease showed that
members of each group manifested similar degrees of
protein-calorie malnutrition [21]. Cirrhosis that results
from alcohol abuse, however, may have more profound
consequences because alcohol is also hepatotoxic [22]. The
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hyde and other products that can cause fatty liver, cirrhosis
with ﬁbrosis, or acute inﬂammation (alcoholic hepatitis)
[23]. Thus, the impact of alcoholic cirrhosis on the devel-
opment and progression of nutritional deﬁcits may be even
greater in patients with alcohol-related liver disease [16]. A
study that compared multiple markers of nutritional status
in cirrhotic patients found a signiﬁcantly greater rate of
malnutrition in the alcoholic patients than in those with
hepatitis C [24].
Another factor that may have contributed to the more
frequent observations of sialadenosis in conjunction with
alcohol use may be reﬂective of the high prevalence of
alcoholic liver disease among patients with cirrhosis. This
has been estimated to be between 60 and 70% in Western
Europe and the United States [23].
During a study that evaluated the oral health status and
oral soft tissue pathologies in a population of candidates for
liver transplantation, [25] the presence of sialadenosis was
recorded. This was assessed for possible associations with
the type of liver disease.
Methods
Between 2004 and 2005, 300 consecutive patients who
were being evaluated for possible liver transplantation at
the University of Pittsburgh’s Starzl Transplant Institute
underwent an oral examination in order to identify their
dental treatment needs and the presence of other oral
abnormalities [25]. Consent to participate in this study had
been approved by the University’s institutional review
board which included patient permission to allow all
medical record information to be placed in a Transplant
Research Registry. The presence of sialadenosis was based
on visible evidence of bilateral parotid gland enlargement
as determined by an experienced dental practitioner (JG)
(Fig. 1). This information, along with patient demograph-
ics and liver disease diagnoses was coded in order to de-
identify the subjects and entered in a spread sheet program
(Microsoft Excel V. II. 3, Redmond, WA).
Data Analysis
The data were imported from the MS-Excel spreadsheet
into SPSS (SPSS for Windows, Version 14, SPSS, Inc.,
Chicago, IL, 2005) and analyzed for statistically signiﬁcant
differences in proportions or means depending on the
measurement level of each dependent variable. Chi-square
and t-tests for independent samples were used for these
analyses.
Results
Sialadenosis was found in 28 subjects (9.3%). Their
demographic characteristics and primary and secondary
liver disease diagnoses are shown in Table 1. Determina-
tion of the primary and secondary disease was based on
patient history, ﬁndings from the physical examination,
laboratory data, and liver biopsy, when necessary.
Alcoholic cirrhosis was the most frequent underlying
primary or secondary liver disease in 11 of the subjects
(39.3%). Hepatitis C was the next most prevalent disease
(six subjects). Both hepatitis C and alcoholic cirrhosis were
Fig. 1 a, b. Typical appearance
of bilateral sialadenosis of the
parotid glands in the study
population
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adenosis were distributed among the seven other liver
diseases shown in Table 1. Statistical analyses found no
signiﬁcant association between sialadenosis and alcoholic
cirrhosis (P = 0.389). Of the 300 liver transplant candi-
dates in this study, 92 (30.7%) had alcoholic cirrhosis as
their primary or secondary liver disease. The rate of sial-
adenosis among these 92 cases was 11.9%.
Laboratory data regarding the nutritional status of these
subjects may have been available but were not retrieved. It
was determined that the identiﬁcation of speciﬁc nutritional
abnormalities and deﬁciencies as well as their etiology
would not be possible due to the complexity and interde-
pendency among all of the metabolic complications
associated with liver failure [11]. A summary of the fea-
tures of nutritional deﬁcits that may be encountered with
cirrhosis are listed in Table 2. It should be noted that
manifestations of malnutrition have been reported to
approach 100% among patients with end-stage liver dis-
ease [19].
Discussion
In this study of 300 candidates for liver transplantation,
sialadenosis was not signiﬁcantly related to alcoholic cir-
rhosis or other underlying liver disease. Nevertheless,
initial observations suspected that sialadenosis developed
only in patients with cirrhosis resulting from alcoholism [2,
26]. This ﬁnding has been supported by other reports which
stated that sialadenosis occurred very rarely in conjunction
with non-alcoholic cirrhosis or in only 10% of alcoholics
who did not have cirrhosis [7, 9]. These concepts were
supported by a postmortem study of 28 alcoholics which
determined that an increase in parotid volume due to
accumulation of adipose tissue was limited to the subjects
who had developed cirrhosis [8]. Other clinical ﬁndings
have shown, however, that sialadenosis could occur in
alcoholics without cirrhosis or whose liver disease had not
progressed to cirrhosis [2]. The disparities among these
reports are reﬂected in an estimated 26–86% prevalence
range for sialadenosis among alcoholics [2, 7]. Similarly,
Table 1 Characteristics of the
28 subjects with sialadenosis
Gender Age Primary liver disease Secondary liver disease
F 43 Autoimmune hepatitis None
F 66 Autoimmune hepatitis None
F 47 Alcoholic cirrhosis None
M 65 Alcoholic cirrhosis None
M 54 Alcoholic cirrhosis None
F 50 Alcoholic cirrhosis None
F 64 Alcoholic cirrhosis None
M 47 Alcoholic cirrhosis None
M 59 Alcoholic cirrhosis Hepatitis C
M 48 Alcoholic cirrhosis Hepatitis C
M 42 Alcoholic cirrhosis Hepatitis C
F 46 Alcoholic cirrhosis Hemochromatosis
M 48 Hemangioma None
M 62 Hemochromatosis None
M 50 Hepatitis C None
M 57 Hepatitis C None
M 66 Hepatitis C None
F 55 Hepatitis C Alcoholic cirrhosis
M 44 Hepatitis C HIV
M 49 Hepatitis C HIV
M 25 Hepatitis, not speciﬁed None
M 64 Non-alcoholic steatohepatitis None
F 54 Non-alcoholic steatohepatitis None
F 65 Non-alcoholic steatohepatitis None
F 54 Postnecrotic cirrhosis, cryptogenic None
M 58 Postnecrotic cirrhosis, cryptogenic None
M 57 Postnecrotic cirrhosis, cryptogenic Non-alcoholic steatohepatitis
F 45 Primary biliary cirrhosis None
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alcoholic cirrhosis among patients with sialadenosis [9].
In the present study, sialadenosis was found in only 11
of the 92 patients (12%) who had alcoholic cirrhosis as
their primary or secondary liver disease. By comparison,
alcoholic cirrhosis was the underlying liver disease in 11 of
the 28 subjects with sialadenosis (39.3%). This rate could
be reﬂective of the fact that alcoholic cirrhosis was the
predominant cause of the liver disease in these liver
transplant candidates (92 of the 300 or 30.7%).
The present study determined that 17 of the 28 subjects
with sialadenosis (60.7%) had seven different non-alcohol-
related liver diseases (Table 1). A possible explanation for
this can be based on the premise that these diseases (with
the exception of the liver hemangioma) have the potential
for progressing to cirrhosis [23, 27]. All 300 subjects had
manifestations of decompensated liver disease with vary-
ing degrees of cirrhosis which was the basis for their being
evaluated for possible liver transplantation. This suggests
that cirrhosis of the liver, irrespective of its etiology, may
be the predisposing factor that was shared by the patients
who had developed sialadenosis.
Initial reports dating back to the 1920s observed that
sialadenosis frequently occurred in malnourished and
vitamin deﬁcient populations [3, 4]. Subsequently, sialad-
enosis has been associated with eating disorders and
diabetes [1, 7, 28] which have signiﬁcant nutritional
interactions. Since patients with these conditions as well as
cirrhosis are likely develop multiple nutritional deﬁcits,
malnutrition or related metabolic complications may be the
underlying pathophysiologic processes that patients with
sialadenosis have in common.
The frequent association between sialadenosis and cir-
rhosis may also be attributed to the likelihood and possible
confounding effect of patients having both liver disease
and diabetes. The liver plays an essential role in the met-
abolic interrelationships and interdependence among
glucose, glycogen, and insulin. Hepatocytes convert glu-
cose to amino acids, fatty acids, and glycogen. Destruction
of hepatocytes results in a decreased storage of glycogen,
increased serum fatty acids, and decreased uptake of glu-
cose by muscles. This results in hyperglycemia as well as
insulin resistance [29]. As a consequence, diabetes can
develop as a complication of cirrhosis, and occurs most
frequently in patients with chronic hepatitis C and non-
alcoholic fatty liver disease (steatohepatitis) [30]. Hemo-
chromatosis is likely to affect the liver and leads to
diabetes mellitus because of iron damage to the islet cells
[31]. Conversely, diabetes, particularly type 2, can cause
liver disease due to altered metabolism of lipids that leads
to an increase in serum lipids resulting in fatty inﬁltration
of the liver (non-alcoholic steatohepatitis [NASH]). This
condition is similar to alcoholic liver disease and can
progress to cirrhosis. Liver disease can also result from the
hepatotoxic effects of some oral hypoglycemic drugs [31].
It is noteworthy that among the 28 subjects with sialade-
nosis in the present study, 13 patients (46%) (Table 1) had
liver diseases that are more likely to be associated with
diabetes. At the time of this study, however, we did not
determine if these transplant candidates also had diabetes.
Although the pathogenesis of sialadenosis has not been
established, a neuropathic process that affects the auto-
nomic innervation of the salivary glands has been
suggested [2, 9, 32–34]. This hypothesis is based on
ultrastructural analyses of parotid tissue obtained from
controls and patients with sialadenosis who had liver dis-
ease or diabetes [33]. Sialadenosis was associated with
acinar cells that were twice as large as compared with
control specimens. In addition, there was evidence of
axonal and myoepithelial cell degeneration with swelling
of the axon ﬁbers and vacuolization [33]. These alterations
were similar to the appearance of axons from rats that were
exposed to high doses of ethanol [35]. Axonal abnormali-
ties have also been identiﬁed by electron microscopy in
diabetic rats [36].
Autonomic neuropathies develop in patients with alco-
holic as well as non-alcoholic liver disease, cirrhosis, and
Table 2 Features associated with nutritional deﬁcits in end-stage
liver disease [10–20]
Generalized malnutrition
Reduced nutritional intake
Nausea and anorexia
Taste disturbances
Dietary restrictions
Cachexia
Muscle wasting
Loss of muscle strength
Reduced protein synthesis and break down of protein leading to
protein loss
Loss of protein through drainage of ascitic ﬂuid
Increased nitrogen excretion
Hypoalbuminemia
Zinc deﬁciency
Increased metabolism and energy expenditure
Weight loss
Reduced body mass index
Decline in body cell mass
Loss of body fat
Generalized malabsorption
Impaired absorption of fat soluble vitamins
Reduced vitamin storage
Increased insulin resistance
Increased resistance to growth hormone
Decreased hepatic glycogen storage
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these diseases, in addition to the eating disorders, may lead
to neuropathy of autonomic ﬁbers that innervate the parotid
glands. This concept, ﬁrst proposed in 1975, [40] could,
therefore, explain the development of sialadenosis in these
patients.
The diagnostic criterion for sialadenosis in this study
was based on visual evidence of bilateral parotid gland
enlargement. Although new technology is available for
imaging the salivary glands, it has not been determined that
this methodology is useful for the evaluation of sialade-
nosis in the absence of any structural or functional
abnormalities in the glands.
The sialadenosis literature appears to have relied pri-
marily on clinical manifestations of sialadenosis, and to
ensure the validity of comparisons with the present study,
the same diagnostic criteria were applied.
Conclusions
Among 28 liver transplant candidates who had sialadenosis,
17 had non-alcohol-related liver diseases. This suggests that
all types of cirrhosis may contribute to the development of
sialadenosis. Metabolic derangements resulting in malnu-
tritionarecommonincirrhosisandmay,therefore,represent
theunderlyingpathophysiologicmechanismforsialadenosis
in patients with liver diseases as well as diabetes and eating
disorders.Ithasbeenproposedthatsialadenosisresultsfrom
a neuropathic process that involves the autonomic innerva-
tion of the salivary glands. This neuropathy may be a
complication of nutritional abnormalities that are frequently
associated with sialadenosis.
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